TDF/EVG Nanoparticle Formulation: Plasma Pharmacokinetics in Humanized Mice
One of the highest priorities of HIV research is to have access to long-acting pharmaceutical formulations for HIV treatment and prevention. Our research aims at fabrication of combination antiretroviral (cARV) drugs loaded nano-system for PReP. Presently we report on the pharmacokinetics of tenofovir disoproxil fumurate (TDF) and elvitegravir (EVG) loaded nanoparticles (TDF+EVG NP) in humanized mice (huNSG). Formulation of cARV…